Trademark: 77756026
Word
SEPLITAN
Status
Dead
Status Code
606
Status Date
Monday, August 15, 2011
Serial Number
77756026
Mark Type
4000
Filing Date
Wednesday, June 10, 2009
Published for Opposition
Tuesday, October 20, 2009
Abandoned Date
Monday, August 15, 2011

Trademark Owner History
Glaxo Group Limited - Owner At Publication

Classifications
5 Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Trademark Events
Aug 15, 2011
Abandonment Notice Mailed - No Use Statement Filed
Aug 15, 2011
Abandonment - No Use Statement Filed
Nov 25, 2010
Notice Of Approval Of Extension Request E-Mailed
Nov 24, 2010
Extension 2 Granted
Nov 23, 2010
Extension 2 Filed
Nov 23, 2010
Teas Extension Received
Aug 3, 2010
Notice Of Approval Of Extension Request E-Mailed
Aug 2, 2010
Extension 1 Granted
Jul 2, 2010
Extension 1 Filed
Aug 2, 2010
Case Assigned To Intent To Use Paralegal
Jul 2, 2010
Teas Extension Received
May 13, 2010
Teas Change Of Correspondence Received
Jan 12, 2010
Noa Mailed - Sou Required From Applicant
Oct 26, 2009
Teas Change Of Correspondence Received
Oct 20, 2009
Official Gazette Publication Confirmation E-Mailed
Oct 20, 2009
Published For Opposition
Sep 16, 2009
Law Office Publication Review Completed
Sep 16, 2009
Assigned To Lie
Sep 8, 2009
Approved For Pub - Principal Register
Sep 1, 2009
Assigned To Examiner
Jun 15, 2009
New Application Office Supplied Data Entered In Tram
Jun 13, 2009
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24